Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 8,009 | 2,895 | 2,656 | 3,249 | 3,729 |
| Gross Profit | 8,009 | 2,895 | 2,656 | 3,249 | 3,729 |
| Operating Expenses | 17,521 | 4,467 | 3,911 | 4,613 | 5,395 |
| Operating Income | -9,512 | -1,572 | -1,255 | -1,364 | -1,666 |
| Other Income | 341 | 544 | 451 | 344 | 544 |
| Pre-tax Income | -9,171 | -1,028 | -804 | -1,020 | -1,122 |
| Income Tax | N/A | N/A | N/A | N/A | -825 |
| Net Income Continuous | -9,171 | -1,028 | -804 | -1,020 | -297 |
| Net Income | $-9,171 | $-1,028 | $-804 | $-1,020 | $-297 |
| EPS Basic Total Ops | -1.54 | -0.14 | -0.14 | -0.14 | -0.07 |
| EPS Basic Continuous Ops | -1.50 | -0.17 | -0.13 | -0.17 | -0.05 |
| EPS Diluted Total Ops | -1.54 | -0.14 | -0.14 | -0.14 | -0.07 |
| EPS Diluted Continuous Ops | -1.50 | -0.17 | -0.13 | -0.17 | -0.05 |
| EBITDA(a) | $-9,457 | $-1,514 | $-1,196 | $-1,304 | $-1,605 |